论文部分内容阅读
目的:研究老年重度心力衰竭在内科的治疗效果。方法:取材于近两年(2014~2016)来我院治疗重度心力衰竭疾病的老年患者,数量为64例,使用传统方法治疗所有患者,并将选取的患者平均分为两组,对其中一组额外使用药物美托洛尔以及厄贝沙坦氢氯噻嗪治疗患者(观察组),剩余一组则作为对照组。结果:所有患者在治疗结束后病情都得到明显的改善,其中观察组的改善效果更为显著,各项观察指标比较,联合使用药物进行治疗的观察组患者明显较优(P<0.05)。结论:内科在治疗重度心力衰竭的老年患者时,使用药物美托洛尔以及厄贝沙坦氢氯噻嗪进行配合治疗,患者的病情改善情况更为显著,各项观察指标也明显提高,作用效果显著,值得在内科中推广使用。
Objective: To study the treatment of senile severe heart failure in medical treatment. Methods: A total of 64 elderly patients with severe heart failure were treated in our hospital in recent two years (2014 ~ 2016). All patients were treated by traditional method. The patients were divided into two groups Patients were additionally treated with metoprolol and irbesartan hydrochlorothiazide (observation group), and the remaining one served as a control group. Results: All the patients got obvious improvement after the treatment, and the improvement effect of the observation group was more obvious. The observation group was better than the observation group (P <0.05). Conclusion: In the treatment of elderly patients with severe heart failure, metoprolol and irbesartan hydrochlorothiazide are used in the treatment of elderly patients. The improvement of the patients’ condition is more obvious, the observation indexes are obviously improved and the effect is obvious. It is worth to promote the use of internal medicine.